2024
Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients
Ringer M, Malinis M, McManus D, Davis M, Shah S, Trubin P, Topal J, Azar M. Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients. Transplant Infectious Disease 2024, 26: e14249. PMID: 38319665, DOI: 10.1111/tid.14249.Peer-Reviewed Original ResearchLength of stayIntensive care unitBaloxavir groupClinical outcomesSecondary outcomesIntensive care unit length of stayRetrospective study of hospitalized patientsEfficacy of baloxavirResolution of feverImmunocompromised adult patientsStudy of hospitalized patientsRetrospective cohort studyAssociated with longer timeResolution of hypoxiaOseltamivir groupInfluenza subtypesImmunocompromised patientsInfluenza ANo significant differenceMedian timeResistance ratesNeuraminidase inhibitorsRetrospective studyBaseline characteristicsAdult patients
2020
Molecular epidemiology of nonpharyngeal group A streptococci isolates in northern Lebanon
Rafei R, Hawli M, Osman M, Khelissa S, Salloum T, Dabboussi F, Tokajian S, Hamze M. Molecular epidemiology of nonpharyngeal group A streptococci isolates in northern Lebanon. Future Microbiology 2020, 15: 1555-1569. PMID: 33236928, DOI: 10.2217/fmb-2020-0072.Peer-Reviewed Original Research
2018
2396. Fosfomycin Resistance Among Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Connecticut, 2017
Snayd M, Leung V, Maloney M, Durante A, Macierowski B, Noel D, Muyombwe A, Razeq J, Banach D. 2396. Fosfomycin Resistance Among Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Connecticut, 2017. Open Forum Infectious Diseases 2018, 5: s714-s715. PMCID: PMC6253430, DOI: 10.1093/ofid/ofy210.2049.Peer-Reviewed Original ResearchState public health laboratoriesCRE isolatesNonsusceptible isolatesFosfomycin resistanceAntimicrobial Susceptibility Testing (EUCAST) criteriaCarbapenem-resistant Enterobacteriaceae infectionsOlder patient ageLimited treatment optionsResistance risk factorsSubstantial proportionEnterobacteriaceae clinical isolatesFosfomycin resistance ratePublic health laboratoriesLaboratory Standards InstituteSusceptibility testing criteriaCRE patientsPatient ageEnterobacteriaceae infectionsTreatment optionsRisk factorsResistance ratesWarrants evaluationCarbapenem resistanceBlaKPC geneCLSI criteria
2017
Prevalence and antibiotic susceptibility patterns of bacteria causing urinary tract infections in Youssef Hospital Center: first report from Akkar governorate, North of Lebanon
Hamze M, Osman M, Mallat H, Raad E. Prevalence and antibiotic susceptibility patterns of bacteria causing urinary tract infections in Youssef Hospital Center: first report from Akkar governorate, North of Lebanon. The International Arabic Journal Of Antimicrobial Agents 2017, 7 DOI: 10.3823/0802.Peer-Reviewed Original ResearchUrinary tract infectionAntibiotic susceptibility patternHospital CenterSusceptibility patternsSusceptibility testingTract infectionsBacterial uropathogensAntibiotic resistance ratesCommon uropathogenic bacteriaAntibiotic susceptibility testingAntimicrobial susceptibility testingUTI symptomsInfected patientsRisk factorsAntibiotic resistance levelsResistance ratesEpidemiological dataUrine specimensHealthcare centersAntibiotic susceptibilityUropathogenic bacteriaProteus sppUropathogensEnterobacter sppPatientsPrevalence and antibiotic susceptibility of ear pathogens isolated from patients in Tripoli, north of Lebanon
Hamze M, Osman M, Mallat H, Achkar M. Prevalence and antibiotic susceptibility of ear pathogens isolated from patients in Tripoli, north of Lebanon. The International Arabic Journal Of Antimicrobial Agents 2017, 7 DOI: 10.3823/0801.Peer-Reviewed Original ResearchUrinary tract infectionAntibiotic susceptibility patternSusceptibility testingBacterial uropathogensSusceptibility patternsSevere public health problemAntibiotic resistance ratesPublic health problemCommon bacterial uropathogensAntibiotic susceptibility testingAntimicrobial susceptibility testingUTI symptomsTract infectionsEar pathogensInfected patientsHospital CenterAntibiotic resistance levelsResistance ratesEpidemiological dataAcinetobacter baumanniiAntibiotic susceptibilityHealth problemsPatientsProteus sppUropathogens
2013
Epidemiology of Streptococcus pneumoniae Serogroup 6 Isolates from IPD in Children and Adults in Germany
van der Linden M, Winkel N, Küntzel S, Farkas A, Perniciaro S, Reinert R, Imöhl M. Epidemiology of Streptococcus pneumoniae Serogroup 6 Isolates from IPD in Children and Adults in Germany. PLOS ONE 2013, 8: e60848. PMID: 23593324, PMCID: PMC3621884, DOI: 10.1371/journal.pone.0060848.Peer-Reviewed Original ResearchConceptsInvasive pneumococcal diseaseSerotypes 6BSerogroup 6 isolatesSerotypes 6ASerotype 6CChildhood pneumococcal conjugate vaccinationSerotype 6DPneumococcal conjugate vaccinationPneumococcal conjugate vaccineLow resistance ratesSerotype 6C isolatesConjugate vaccinationPCV periodPCV7 vaccinationPneumococcal diseaseConjugate vaccineMultilocus sequence typingChildhood vaccinationResistance ratesVaccinationPrevalenceSequence typingStatistical significanceAntibiotic resistanceSerotype 6D.
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply